Alarm.com (NASDAQ:ALRM) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $65.00 price target on the stock. This represents a 18.3% upside from the current price of $54.96. |
Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $48.00 price target on the stock. This represents a 92.3% upside from the current price of $24.96. |
CalAmp (NASDAQ:CAMP) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $23.00 price target on the stock. This represents a 179.8% upside from the current price of $8.22. |
CalAmp (NASDAQ:CAMP) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $18.00 price target on the stock. This represents a 119.0% upside from the current price of $8.22. |
CalAmp (NASDAQ:CAMP) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $8.22. |
CalAmp (NASDAQ:CAMP) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $17.00 price target on the stock. This represents a 106.8% upside from the current price of $8.22. |
CeriBell (NASDAQ:CBLL) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $30.00 price target on the stock. This represents a 12.9% upside from the current price of $26.58. |
CeriBell (NASDAQ:CBLL) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $26.58. |
CeriBell (NASDAQ:CBLL) is now covered by analysts at TD Cowen. They set a "buy" rating and a $31.00 price target on the stock. This represents a 16.6% upside from the current price of $26.58. |
CeriBell (NASDAQ:CBLL) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $32.00 price target on the stock. This represents a 20.4% upside from the current price of $26.58. |
CeriBell (NASDAQ:CBLL) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $30.00 price target on the stock. This represents a 12.9% upside from the current price of $26.58. |
CeriBell (NASDAQ:CBLL) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $32.00 price target on the stock. This represents a 20.4% upside from the current price of $26.58. |
Celestica (NYSE:CLS) (TSE:CLS) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $91.00 price target on the stock. This represents a 20.5% upside from the current price of $75.54. |
CMS Energy (NYSE:CMS) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $76.00 price target on the stock. This represents a 10.5% upside from the current price of $68.76. |
Krispy Kreme (NASDAQ:DNUT) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $14.00 price target on the stock. This represents a 18.1% upside from the current price of $11.85. |
Eaton (NYSE:ETN) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $382.00 price target on the stock. This represents a 13.8% upside from the current price of $335.65. |
Fabrinet (NYSE:FN) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $280.00 price target on the stock. This represents a 24.1% upside from the current price of $225.59. |
Geron (NASDAQ:GERN) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $8.00 price target on the stock. This represents a 93.2% upside from the current price of $4.14. |
Hubbell (NYSE:HUBB) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $535.00 price target on the stock. This represents a 23.1% upside from the current price of $434.72. |
TuHURA Biosciences (NASDAQ:HURA) is now covered by analysts at Maxim Group. They set a "buy" rating and a $15.00 price target on the stock. This represents a 206.1% upside from the current price of $4.90. |
MSA Safety (NYSE:MSA) is now covered by analysts at B. Riley. They set a "buy" rating and a $200.00 price target on the stock. This represents a 21.2% upside from the current price of $164.95. |
Sable Offshore (NYSE:SOC) is now covered by analysts at Johnson Rice. They set a "buy" rating and a $30.00 price target on the stock. This represents a 32.3% upside from the current price of $22.68. |
Upstream Bio (NASDAQ:UPB) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.The current price is $26.63. |
Upstream Bio (NASDAQ:UPB) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $26.63. |
Upstream Bio (NASDAQ:UPB) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $38.00 price target on the stock. This represents a 42.7% upside from the current price of $26.63. |
Upstream Bio (NASDAQ:UPB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $75.00 price target on the stock. This represents a 181.6% upside from the current price of $26.63. |
ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $34.00 price target on the stock. This represents a 70.4% upside from the current price of $19.95. |